LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY

被引：0
|
作者：
Howard, James
Bril, Vera
Tuan Vu
Karam, Chafic
Peric, Stojan
De Bleecker, Jan
Murai, Hiroyuki
Meisel, Andreas
Beydoun, Said
Pasnoor, Mamatha
Guglietta, Antonio
T'joen, Caroline
Utsugisawa, Kimiaki
Mantegazza, Renato
机构：
来源：
MUSCLE & NERVE | 2022年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
108
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. MUSCLE & NERVE, 2022, 65 : S9 - S10
  • [2] Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT plus Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    Ulrichts, Peter
    T'joen, Caroline
    Brauer, Edward
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. NEUROLOGY, 2022, 99 (23) : S37 - S38
  • [3] Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT plus Study
    Pasnoor, Mamatha
    Bril, Vera
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Vu, Tuan
    Ulrichts, Peter
    Van Hoorick, Benjamin
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    Howard, James
    [J]. NEUROLOGY, 2023, 100 (17)
  • [4] Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT plus study
    Bril, Vera
    Pasnoor, Mamatha
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Vu, Tuan
    Ulrichts, Peter
    Van Hoorick, Benjamin
    T'Joen, Caroline
    Kaprielian, Roger
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    Howard, James F., Jr.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [5] Long-term safety, tolerability, and efficacy of Efgartigimod in patients with Generalized Myasthenia Gravis: concluding analyses from the ADAPT plus study
    Ashcraft, E.
    Bril, V.
    Pasnoor, M.
    Karam, C.
    Peric, S.
    De Bleecker, J.
    Murai, H.
    Meisel, A.
    Beydoun, S.
    Vu, T.
    Ulrichts, P.
    Van Hoorick, B.
    T'joen, C.
    Utsugisawa, K.
    Verschuuren, J.
    Mantegazza, R.
    Howard, J.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S179 - S179
  • [6] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Howard, James
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan
    Mantegazza, Renato
    [J]. NEUROLOGY, 2023, 100 (17)
  • [7] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Ritt, Elissa
    Howard, James F., Jr.
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan L.
    Mantegazza, Renato
    [J]. ANNALS OF NEUROLOGY, 2023, 94 : S244 - S245
  • [8] LONG-TERM ASSESSMENT OF EFGARTIGIMOD IN PATIENTS WITH GENERALISED MYASTHENIA GRAVIS: ADAPT plus STUDY INTERIM RESULTS
    Jacob, Saiju
    Howard, James
    Bril, Vera
    Peric, Stojan
    De Bleecker, Jan
    T'joen, Carolin
    Travers, Jackalyne
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [9] Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT plus ): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
    Howard Jr, James F.
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said R.
    Pasnoor, Mamatha
    Guglietta, Antonio
    Van Hoorick, Benjamin
    Steeland, Sophie
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. FRONTIERS IN NEUROLOGY, 2024, 14
  • [10] Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: phase 3 adapt study results
    Mantegazza, R.
    Bril, V.
    Vu, T.
    Karam, C.
    Peric, S.
    Margania, T.
    Murai, H.
    Biliska, M.
    Shakarishvili, R.
    Smilowski, M.
    Guglietta, A.
    Ulrichts, P.
    Vangeneugden, T.
    Utsugisawa, K.
    Verschuuren, J.
    Howard, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 80 - 80
12345